Abstract

Prolongation of action potential duration (APD) has been widely believed to be positively associated with, and indeed a trigger of early afterdepolarizations (EADs). In the clinical setting, QT interval prolongation, which indicates underlying prolongation of APD, is an important risk indicator of torsades de pointes (TdP), a ventricular tachyarrhythmia triggered by EADs. However, some studies have shown that positive APD-EAD relationship does not always hold. For example, Alfuzosin and ranolazine prolong QT interval clinically but are not linked to TdP.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call